The study authors conducted a systematic review and meta-analysis to assess the overall efficacy and safety of low-dose direct oral anticoagulants vs placebo on a background of antiplatelet therapy.
Cardiovascular events are the leading cause of death among patients with chronic kidney disease, and metabolic acidosis in this population is underdiagnosed.
Risk for adverse events attributable to statins low when used for primary prevention of cardiovascular disease.
Researchers conducted a prospective cohort study to evaluate the prognostic role of thyroid dysfunction in acute myocardial infarction.
The goal of this study was to determine the relationship between subclinical coronary artery disease and the severity of nonalcoholic fatty liver disease.
Cardiovascular drugs do not affect COVID-19 outcomes.
Messenger RNA (mRNA) from COVID-19 vaccines is not detectable in breast milk.
Individuals with South Asian ancestry have an increased risk for atherosclerotic cardiovascular disease compared with those with European ancestry.
A 6-month program of intra-dialytic cycling improved left ventricular mass.
Investigators assessed outcomes following discontinuation of statins while maintaining the use of other drugs in older patients receiving polypharmacy.
